It has been used extensively in animal studies, human cell models, and increasingly in off-label therapeutic settings, with minimal toxicity or organ stress reported
Current Pharmaceutical Design (2018) This comparative study examines BPC-157's angiogenic properties alongside standard growth factors including VEGF (Vascular Endothelial Growth Factor) and bFGF (basic Fibroblast Growth Factor) in established wound healing models
That remains to be seen
These include: Neurological symptoms : tingling or numbness in hands and feet (paraesthesia), difficulty walking, balance problems, memory difficulties, or mood changes Haematological signs : ongoing fatigue, weakness, pale skin, or shortness of breath suggesting anaemia hasn't resolved Glossitis : a sore, red tongue that hasn't improved Cognitive issues : continued difficulty concentrating or memory problems These symptoms, particularly progressive neurological deficits or severe anaemia with cardiorespiratory compromise, may require urgent medical attention
Potential Links to Hair Follicle Biology Research has also examined the peptide in relation to dermal papilla cells (DPCs), specialized fibroblasts implicated in hair follicle development
